Author: Zacks Small Cap Research

123455030 / 491 POSTS
NASDAQ:DTSSBeijing, China-based Datasea (NASDAQ:DTSS) is an emerging technology company that develops information technology (IT) systems and network security solutions, leveraging its proprietary technologies and IP to provide complete security solu ...
By Brian Marckx, CFANASDAQ:EYEGREAD THE FULL EYEG RESEARCH REPORTFDA Approves IDE for OBG-PRK Pivotal Study, Topline Results Expected Later This Year…The major recent news on the operating front was yesterday’s announcement that the FDA approved EyeG ...
By Brian Marckx, CFANASADAQ:NAOVREAD THE FULL NAOV RESEARCH REPORTQ1 2019 Results / Business UpdateNanoVibronix (NASDAQ:NAOV) filed their 10-Q for Q1 2019 ending March 31st and released a corresponding business update. Relative to the financials, rev ...
By David Bautz, PhDTSX:MDNA.TO | OTC:MDNAFREAD THE FULL MDNA.TO RESEARCH REPORTBusiness UpdateMedicenna Therapeutics Corp. (TSX:MDNA.TO) (OTC:MDNAF) is a clinical stage immunotherapy company developing novel versions of the cytokines Interleukin (IL) ...
By Brian Marckx, CFAOTC:CVALF | CVE:COV.VREAD THE FULL CVALF RESEARCH REPORTFiscal Q2 2019 ResultsCovalon Technologies (OTC:CVALF) (CVE:COV.V) reported financial results for their fiscal 2019 second quarter ending March 31st and provided a business u ...
By Ian Gilson, PhD, CFANASDAQ:UHALREAD THE FULL UHAL RESEARCH REPORT HEREAMERCO (NASDAQ:UHAL) reported year-end financials on Wednesday, May 29, 2019. Both truck rental and all moving and storage revenue were about 1% below our estimates. Due to ...
By John Vandermosten, CFANASDAQ:ACHVREAD THE FULL ACHV RESEARCH REPORTAchieve Life Sciences, Inc. (NASDAQ:ACHV) released its first quarter results for 2019 and filed the companion 10-Q on May 15, 2019. An investor conference call was held following t ...
By John Vandermosten, CFANASDAQ:VVUSOn May 22nd, the FDA issued a letter to Vivus (NASDAQ:VVUS) claiming that the company had made false or misleading claims and/or representations about the efficacy and risks of Qsymia. The letter appears to have be ...
By Brian Marckx, CFAOTC:SNWVREAD THE FULL SNWV RESEARCH REPORTQ1 Results, Operational Update: International Sales Disappoint But U.S. Strategy Coming Together. Utilization-Based Revenue on the Horizon….SANUWAVE (OTC:SNWV) reported financial results f ...
By John Vandermosten, CFANASDAQ:TTNPREAD THE FULL TTNP RESEARCH REPORTFirst Quarter 2019 Financial and Operational ResultsSeveral important events took place in the first quarter of 2019 for Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) which were report ...
123455030 / 491 POSTS